Robust predictive markers are needed for early detection of trastuzumab-related cardiac dysfunction in breast cancer
Crossref DOI link: https://doi.org/10.1007/s12282-017-0767-y
Published Online: 2017-03-08
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Altundag, Kadri http://orcid.org/0000-0003-3357-0096
License valid from 2017-03-08